Cough medicines in the spotlight

Scheduling decisions have been made for leading cough and cold products Two widely used cough suppression treatments were considered for rescheduling at the March 2024 meeting of the Therapeutic Goods Administration's (TGA) Advisory Committee on Medicines Scheduling. The recently released interim decisions from the meeting show that a proposal to change the scheduling of cough